Pfizer (PFE) Tops Q1 EPS by 24c; offers guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $25.09 -0.48%
Revenue Growth %: -1.8%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -1.8%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.92, $0.24 better than the analyst estimate of $0.68. Revenue for the quarter came in at $13.72 billion versus the consensus estimate of $14.09 billion.
GUIDANCE:
Pfizer sees FY2025 EPS of $2.80-$3.00, versus the consensus of $2.95. Pfizer sees FY2025 revenue of $61-64 billion, versus the consensus of $62.92 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Texas AG Paxton announces ongoing investigation into Carnival over data breach
- EU approves Arrowhead's plozasiran for rare triglyceride disorder
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
